Genenta Science S.p.A annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Genenta Science S.p.A Capital Expenditures (CapEx) Growth & History (GNTA)
Genenta Science S.p.A's capital expenditures (capex) was €7,625 for fiscal 2025.
View full Genenta Science S.p.A company overviewGenenta Science S.p.A annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €7,625 | €3,157 | +70.66% |
| 2024 | 2024-12-31 | €4,468 | −€9,323 | −67.60% |
| 2023 | 2023-12-31 | €13,791 | −€13,279 | −49.05% |
| 2022 | 2022-12-31 | €27,070 | €18,061 | +200.48% |
| 2021 | 2021-12-31 | €9,009 | −€11,862 | −56.83% |
| 2020 | 2020-12-31 | €20,871 | — | — |
Genenta Science S.p.A capital expenditures (capex) trends
Over the last five fiscal years, Genenta Science S.p.A's capital expenditures (capex) decreased from €20,871 to €7,625, a change of −€13,246.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genenta Science S.p.A source filings ↗